Large gap with delayed quotes
|
Official
09/29/2026
-
02:04:00
|
Bid
09/28/2026 -
22:00:00
|
Bid Volume |
Ask
09/28/2026 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
10.46
-0.20
(
-1.88% )
|
10.44
|
5,400 |
10.46
|
5,400 |
Analysis date: 25.09.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 22.05.2026.
Quality
Strong
Strong
Three stars since 18.09.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 10.07.2026 at a price of 9.09.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 18.09.2026.
4wk Rel Perf
40.52%
40.52%
The four-week dividend-adjusted overperformance versus SP500 is 40.52%.
Risk
High
High
High, no change over 1 year.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.58%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.95%.
Mkt Cap in $bn
0.72
0.72
With a market capitalization <$2bn, GINKGO BIOWORKS HOLDINGS A is considered a small-cap stock.
G/PE Ratio
3.15
3.15
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
-3.39
-3.39
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
10.69%
10.69%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
274
274
For 1% of index variation, the stock varies on average by 2.74%.
Correlation
0.38
0.38
Stock movements are strongly independent of index variations.
Value at Risk
10.13
10.13
The value at risk is estimated at USD 10.13. The risk is therefore 95.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
21.12.2021
21.12.2021